Long-Term Efficacy of Evolocumab in Patients with or Without Multivessel Coronary Disease

Daniel J. McClintick,Michelle L. O'Donoghue,Gaetano M. De Ferrari,Jorge Ferreira,Xinhui Ran,Kyungah Im,Mary Elliott-Davey,Bei Wang,Maria Laura Monsalvo,Dan Atar,Anthony Keech,Robert P. Giugliano,Marc S. Sabatine

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2024）

引用 0|浏览23

暂无评分

关键词

coronary artery disease,evolocumab,low-density lipoprotein cholesterol,major adverse cardiovascular events,proprotein convertase subtilisin/ kexin type 9 inhibitor

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要